Please login to the form below

Not currently logged in
Email:
Password:

Shire lines up Advanced BioHealing deal

Shire is to acquire Advanced BioHealing, a US-based regenerative medicine company, for $750m in cash

Shire has acquired Advanced BioHealing, a US-based regenerative medicine company, for $750m in cash. The deal will see Shire own the global rights for DERMAGRAFT, a regenerative bio-engineered skin substitute indicated for use in the treatment of diabetic foot ulcers greater than six weeks in duration, and will continue to invest in the development of new indications and new geographies, pending regulatory approvals.  

Mike Cola, president of Shire's Specialty Pharmaceuticals business, said: "This acquisition is a strong and complementary strategic fit for Shire. We will invest in the strengths of Advanced BioHealing's specialist commercial team, its manufacturing and its product development.

“We believe there's an opportunity to create more value from DERMAGRAFT and Advanced BioHealing's proprietary technology and that with Advanced BioHealing's team joining Shire, we can build Advanced BioHealing into an exciting new business providing regenerative medicine for patients' unmet needs."

The deal is subject to customary conditions, including obtaining anti-trust clearances.

18th May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics